HA
Haw Par Corporation Limited
HAWPF · OTC
$10.80 +0.00% (+$0.00)
Market Cap $3.39B
P/E Ratio 12.78x
Div. Yield 2.63%
ROE 6.15%
Bulios Fair Price
$12.74
18.0% upside
Current Price
$10.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAWPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
63 /100
Fair P/E 12.78x
EV/EBITDA 36.01x
P/S 14.75x
Growth
81 /100
Growing EPS growth 21.44%
Rev. growth 8.06%
FCF growth 133.20%
Profitability
100 /100
Strong Gross margin 55.99%
Net margin 115.44%
Op. margin 29.17%
Quality
18 /100
Poor ROIC 1.46%
ROE 6.15%
ROA 6.01%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 7.13x
Int. coverage 44.05x
Stability
60 /100
Moderate Beta 0.16x
Rev. volatility 17.05%
EPS volatility 21.25%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAWPF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore